CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

July 30th, 2014

Heart Groups Update Guidelines on Stable Ischemic Heart Disease

The American College of Cardiology and the American Heart Association have issued a focused update to their 2012 guideline on diagnosing and managing patients with stable ischemic heart disease (IHD).

The update, published in the Journal of the College of Cardiology, includes a new section on the role of invasive coronary angiography for the diagnosis of coronary artery disease (CAD) in patients with suspected stable IHD. Angiography is:

  • “useful” in patients with presumed stable IHD who continue to have “unacceptable” symptoms despite guideline-directed medical therapy and who are open to, and eligible for, coronary revascularization;

  • “reasonable” to determine the extent of CAD in patients with suspected stable IHD who have a high likelihood of severe IHD based on clinical characteristics and noninvasive testing;

  • “reasonable” in those with suspected symptomatic stable IHD who cannot undergo diagnostic stress testing when it’s likely that the findings will warrant “important changes to therapy.”

In addition, the groups now say that chelation is of uncertain value in reducing cardiovascular events in patients with stable IHD (the 2012 guideline said chelation was not recommended), and a heart team approach to revascularization is now advised for patients with diabetes and multivessel CAD.

Categories: Uncategorized


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

One Response to “Heart Groups Update Guidelines on Stable Ischemic Heart Disease”

  1. Joel Wolkowicz, MDCM says:
    August 17, 2014 at 6:40 pm

    “reasonable” in those with suspected symptomatic stable IHD who cannot undergo diagnostic stress testing when it’s likely that the findings will warrant “important changes to therapy.”

    Which patients with stable CAD cannot undergo diagnostic stress testing?